-
June 10, 2019PREVIEW
Results of two studies published in JAMA, the SUNSHINE and AMATERASU trials, showed that vitamin D supplementation did not significantly improve progression-free survival in patients with...
-
April 16, 2019PREVIEW
Use of apixaban (Eliquis—Bristol-Myers Squibb, Pfizer) as thromboprophylaxis in intermediate- to high-risk ambulatory patients receiving chemotherapy for various types of cancers reduced the risk...
-
February 26, 2019PREVIEW
Supplementation with high-dose vitamin D in older adults did not lower the incidence of invasive cancer or adverse cardiovascular (CV) events compared with placebo, according to results of the...
-
February 5, 2019PREVIEW
In patients with nonmetastatic resected pancreatic adenocarcinoma, adjuvant chemotherapy with a modified FOLFIRINOX regimen led to significantly longer survival than treatment with gemcitabine (...
-
September 18, 2018PREVIEW
Patients with cancer who used complementary medicines had higher refusal rates of surgery, chemotherapy, radiotherapy, and hormone therapy compared with those who did not use these alternative...
Pages
